View digital versions
of our magazines
exactly as they
appear in print

International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
European Pharmaceutical Contractor
European Pharmaceutical Contractor
The EPC edition is designed to fill a unique position in pharmaceutical contractor publishing.
Ethics & Risk Management
Human Factor Analysis

Lessons Learned

Clara Heering
at ICON believes that employing human factor analysis has the potential to radically improve trial efficiency through a better approach in the identification of risks and errors.
CPhI Worldwide returns, and will be taking place this year in Barcelona on 4-6 October 2016. The event offers networking opportunities, as well as encourages collaboration among pharma products and business solutions.
Manufacturing Efficiency

Reliable Robotics

Robots are already proving more than their worth in fields such as food and drink, but can they be utilised in the escalating pharma market? Mike Wilson at ABB Robotics discusses how the need to minimise human error and diminish contamination can pave the way for an increase in automated processes.

Legal & Regulatory
ICH E6 (R2) Addendum

Game Changer

The new ICH guidance will be implemented in November 2016, which will have a profound effect on the management of clinical trials. Nick Neri at ERT outlines some of the steps that pharma companies need to take in order to remain compliant.



Website design and development by Rubler Studio
spacer Banner of Webinars.homepage on Samedan

Member login

E-mail address:

Remember me

News and Press Releases

Arcis Biotechnology launches IVD for the preparation of DNA from blood

Provider of nucleic acid sample preparation solutions announces the launch of its DNA Blood Kit
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

Industry Events

Pharma & Device Packaging and Labeling West Coast 2016

16-17 November 2016, San Mateo, CA, USA

Following popular demand and our 9 year success in Philadelphia, we are delighted to be expanding the Pharma & Device Packaging and Labeling series to San Mateo this November!
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement